Magdalena Pajor1, Jonathan Sogin2, Randy W Worobo2, Piotr Szweda3. 1. Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, G. Narutowicza Street 11/12, 80-233, Gdańsk, Poland. magdalena.pajor@pg.edu.pl. 2. Department of Food Science, Cornell University, Stocking Hall, Ithaca, NY, 14853-7201, USA. 3. Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, G. Narutowicza Street 11/12, 80-233, Gdańsk, Poland.
Abstract
OBJECTIVE: A Paenibacillus strain isolated in previous research exhibited antimicrobial activity against relevant human pathogens including Staphylococcus aureus and Listeria monocytogenes. In this study, the genome of the aforementioned strain, designated as MP1, was shotgun sequenced. The draft genome of strain MP1 was subject to multiple genomic analyses to taxonomically characterize it and identify the genes potentially responsible for its antimicrobial activity. RESULTS: Here we report the draft genome sequence of an antimicrobial producing Paenibacillus strain, MP1. Average Nucleotide Identity (ANI) analysis established strain MP1 as a new strain of the previously characterized Paenibacillus alvei. The genomic analysis identified several putative secondary metabolite clusters including seven Nonribosomal Peptide Synthetase clusters (NRPS) (> 10,000 nt), one bacteriocin or other unspecified Ribosomally Synthesized and Post-Translationally modified Peptide Product (RiPP), one lanthipeptide, and six hybrid clusters (NRPS-Type I Polyketide synthase (T1PKS) and NRPS-trans Amino Transferase Polyketide Synthase (AT-PKS)).
OBJECTIVE: A Paenibacillus strain isolated in previous research exhibited antimicrobial activity against relevant human pathogens including Staphylococcus aureus and Listeria monocytogenes. In this study, the genome of the aforementioned strain, designated as MP1, was shotgun sequenced. The draft genome of strain MP1 was subject to multiple genomic analyses to taxonomically characterize it and identify the genes potentially responsible for its antimicrobial activity. RESULTS: Here we report the draft genome sequence of an antimicrobial producing Paenibacillus strain, MP1. Average Nucleotide Identity (ANI) analysis established strain MP1 as a new strain of the previously characterized Paenibacillus alvei. The genomic analysis identified several putative secondary metabolite clusters including seven Nonribosomal Peptide Synthetase clusters (NRPS) (> 10,000 nt), one bacteriocin or other unspecified Ribosomally Synthesized and Post-Translationally modified Peptide Product (RiPP), one lanthipeptide, and six hybrid clusters (NRPS-Type I Polyketide synthase (T1PKS) and NRPS-trans Amino Transferase Polyketide Synthase (AT-PKS)).
Authors: You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart Journal: Nucleic Acids Res Date: 2011-06-14 Impact factor: 16.971
Authors: Chirag Jain; Luis M Rodriguez-R; Adam M Phillippy; Konstantinos T Konstantinidis; Srinivas Aluru Journal: Nat Commun Date: 2018-11-30 Impact factor: 14.919
Authors: David Arndt; Jason R Grant; Ana Marcu; Tanvir Sajed; Allison Pon; Yongjie Liang; David S Wishart Journal: Nucleic Acids Res Date: 2016-05-03 Impact factor: 16.971
Authors: Tatiana Tatusova; Michael DiCuccio; Azat Badretdin; Vyacheslav Chetvernin; Eric P Nawrocki; Leonid Zaslavsky; Alexandre Lomsadze; Kim D Pruitt; Mark Borodovsky; James Ostell Journal: Nucleic Acids Res Date: 2016-06-24 Impact factor: 16.971
Authors: Magdalena Pajor; Randy W Worobo; Sławomir Milewski; Piotr Szweda Journal: Int J Environ Res Public Health Date: 2018-09-14 Impact factor: 3.390
Authors: Darren Shu Jeng Ting; Imran Mohammed; Rajamani Lakshminarayanan; Roger W Beuerman; Harminder S Dua Journal: Front Med (Lausanne) Date: 2022-06-16